HK1105279A1 - Use of growth hormone secretagogues for stimulating the motility of the gastrointestinal system - Google Patents

Use of growth hormone secretagogues for stimulating the motility of the gastrointestinal system

Info

Publication number
HK1105279A1
HK1105279A1 HK07113167.3A HK07113167A HK1105279A1 HK 1105279 A1 HK1105279 A1 HK 1105279A1 HK 07113167 A HK07113167 A HK 07113167A HK 1105279 A1 HK1105279 A1 HK 1105279A1
Authority
HK
Hong Kong
Prior art keywords
motility
stimulating
growth hormone
gastrointestinal system
hormone secretagogues
Prior art date
Application number
HK07113167.3A
Other languages
English (en)
Inventor
Wiliam J Polvino
Original Assignee
Helsinn Healthcare Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Helsinn Healthcare Sa filed Critical Helsinn Healthcare Sa
Publication of HK1105279A1 publication Critical patent/HK1105279A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK07113167.3A 2004-08-12 2007-11-30 Use of growth hormone secretagogues for stimulating the motility of the gastrointestinal system HK1105279A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US60095904P 2004-08-12 2004-08-12
PCT/US2005/028851 WO2006020930A2 (en) 2004-08-12 2005-08-12 Method of stimulating the motility of the gastrointestinal system using growth hormone secretagogues

Publications (1)

Publication Number Publication Date
HK1105279A1 true HK1105279A1 (en) 2008-02-06

Family

ID=35908211

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07113167.3A HK1105279A1 (en) 2004-08-12 2007-11-30 Use of growth hormone secretagogues for stimulating the motility of the gastrointestinal system

Country Status (17)

Country Link
US (3) US20070191283A1 (da)
EP (1) EP1789067B8 (da)
JP (1) JP2008509930A (da)
KR (2) KR101380200B1 (da)
CN (1) CN101076349B (da)
AU (1) AU2005272598B2 (da)
CA (1) CA2576238C (da)
CY (1) CY1113067T1 (da)
DK (1) DK1789067T3 (da)
ES (1) ES2388501T3 (da)
HK (1) HK1105279A1 (da)
IL (1) IL181249A (da)
MX (1) MX2007001477A (da)
PL (1) PL1789067T3 (da)
PT (1) PT1789067E (da)
SI (1) SI1789067T1 (da)
WO (1) WO2006020930A2 (da)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8039456B2 (en) * 2004-08-12 2011-10-18 Helsinn Therapeutics (U.S.), Inc. Method of stimulating the motility of the gastrointestinal system using ipamorelin
DK1789067T3 (da) * 2004-08-12 2012-08-27 Helsinn Healthcare Sa Anvendelse af væksthormonsekretionsfremkaldere til stimulering af mave-tarm-systemets motilitet
CA2576915A1 (en) * 2004-08-18 2006-03-02 Elixir Pharmaceuticals, Inc. Growth-hormone secretagogues
EP1937262B1 (en) * 2005-09-29 2019-05-08 Ipsen Pharma Composition for use in treating gastrointestinal dysmotility
US8088733B2 (en) * 2006-07-06 2012-01-03 Tranzyme Pharma Inc. Methods of using macrocyclic agonists of the ghrelin receptor for treatment of gastrointestinal motility disorders
WO2008095063A1 (en) 2007-01-31 2008-08-07 Dana-Farber Cancer Institute, Inc. Stabilized p53 peptides and uses thereof
KR20090107088A (ko) 2007-02-09 2009-10-12 트랜자임 파르마 인크 거대고리 그렐린 수용체 조절제 및 이의 사용 방법
EP2508531B1 (en) 2007-03-28 2016-10-19 President and Fellows of Harvard College Stitched polypeptides
TWI429436B (zh) * 2007-04-10 2014-03-11 Helsinn Therapeutics Us Inc 使用生長激素促泌素治療或預防嘔吐之方法
JP2011507842A (ja) * 2007-12-21 2011-03-10 ヘルシン・セラピューティクス・ユーエス・インコーポレイテッド 消化器系の運動をイパモレリンを用いて刺激する方法
NZ588895A (en) * 2008-05-13 2012-07-27 Clarassance Inc Recombinant human CC10 (rhCC10 aka uteroglobin) and compositions thereof for use in the treatment of nasal rhinitis
BRPI0915968B1 (pt) * 2008-07-18 2021-11-23 Trinity Therapeutics, inc Uso de polipeptídeo purificado para tratar infecção pelo vírus da dengue
JP5889506B2 (ja) * 2008-09-12 2016-03-22 丸善製薬株式会社 毛乳頭細胞増殖促進剤
UA105657C2 (uk) * 2009-02-27 2014-06-10 Хелсінн Терапьютікс (Ю.Ес.), Інк. Поліпшені способи лікування мігрені на основі анамореліну
EP2493910A1 (en) 2009-10-30 2012-09-05 Tranzyme Pharma, Inc. Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same
SI2603600T1 (sl) 2010-08-13 2019-04-30 Aileron Therapeutics, Inc. Peptidomimetični makrocikli
AU2012326026B2 (en) 2011-10-18 2017-04-13 Aileron Therapeutics, Inc. Peptidomimetic macrocyles
WO2013119800A1 (en) 2012-02-07 2013-08-15 Massachusetts Institute Of Technology Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness
WO2013123267A1 (en) 2012-02-15 2013-08-22 Aileron Therapeutics, Inc. Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
CN112500466B (zh) 2012-02-15 2022-05-03 艾瑞朗医疗公司 拟肽大环化合物
AU2013337388B2 (en) 2012-11-01 2018-08-02 Aileron Therapeutics, Inc. Disubstituted amino acids and methods of preparation and use thereof
AU2013370966A1 (en) 2012-12-24 2015-06-18 Neurogastrx, Inc. Methods for treating GI tract disorders
PT2984073T (pt) 2013-02-08 2019-01-21 Gen Mills Inc Produto alimentar com baixo teor de sódio
WO2014144231A1 (en) 2013-03-15 2014-09-18 Massachusetts Institute Of Technology Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness
WO2015023675A2 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
AU2014338991B2 (en) 2013-10-22 2020-06-11 Novimmune S.A. Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of TLR4 ligands and other biomarkers
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
WO2015200369A1 (en) 2014-06-24 2015-12-30 Neurogastrx, Inc. Prodrugs of metopimazine
CA2955229C (en) 2014-07-17 2020-03-10 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
BR112017005598A2 (pt) 2014-09-24 2017-12-12 Aileron Therapeutics Inc macrociclos peptidomiméticos e usos dos mesmos
JP2017531026A (ja) 2014-10-20 2017-10-19 ファーマシューティカル マニュファクチュアリング リサーチ サービシズ，インコーポレーテッド 徐放性乱用抑止性液体充填剤形
WO2016138099A1 (en) 2015-02-24 2016-09-01 Massachusetts Institute Of Technology Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness
KR20170129879A (ko) 2015-03-20 2017-11-27 에일러론 테라퓨틱스 인코포레이티드 펩티드모방 거대고리 및 이의 용도
TW202246215A (zh) 2015-12-18 2022-12-01 美商亞德利克斯公司 作為非全身ｔｇｒ５促效劑之經取代之４－苯基吡啶化合物
US10836757B1 (en) 2020-04-02 2020-11-17 Neurogastrx, Inc. Polymorphic forms of metopimazine
CN111643501A (zh) * 2020-04-27 2020-09-11 长春金赛药业有限责任公司 Gensci073或其类似物的用途

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0622717B1 (en) * 1993-04-30 1998-12-30 STMicroelectronics S.r.l. Temperature stable circuit for recycling discharge current during the driving of an inductive load
US5434171A (en) * 1993-12-08 1995-07-18 Eli Lilly And Company Preparation of 3,4,4-trisubstituted-piperidinyl-N-alkylcarboxylates and intermediates
WO1995017423A1 (en) * 1993-12-23 1995-06-29 Novo Nordisk A/S Compounds with growth hormone releasing properties
CN1211991A (zh) * 1995-12-22 1999-03-24 诺沃挪第克公司 具有生长激素释放性质的化合物
TW432073B (en) * 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
DE69734215T2 (de) * 1996-07-22 2006-06-29 Novo Nordisk A/S Verbindungen mit Wachstumshormon-freisetzenden Eigenschaften
US6286927B1 (en) * 1997-12-25 2001-09-11 Canon Kabushiki Kaisha Ink jet element substrate and ink jet head that employs the substrate, and ink jet apparatus on which the head is mounted
US6494563B2 (en) * 1997-12-25 2002-12-17 Canon Kabushiki Kaisha Ink jet element substrate and ink jet head that employs the substrate, and ink jet apparatus on which the head is mounted
US6083908A (en) * 1998-01-16 2000-07-04 Novo Nordisk A/S Compounds with growth hormone releasing properties
US6303620B1 (en) * 1998-05-11 2001-10-16 Novo Nordisk A/S Compounds with growth hormone releasing properties
RU2243215C2 (ru) * 1998-05-11 2004-12-27 Ново Нордиск А/С Производные пиперидинкарбоновых кислот, фармацевтические композиции, содержащие их, способ стимуляции секреции гормона роста
US6919315B1 (en) * 1998-06-30 2005-07-19 Novo Nordisk A/S Compounds with growth hormone releasing properties
KR100907638B1 (ko) * 1998-06-30 2009-07-14 노보 노르디스크 에이/에스 성장 호르몬 방출성을 가지는 화합물
US6566337B1 (en) * 1998-11-03 2003-05-20 Novo Nordisk A/S Compounds with growth hormone releasing properties
TW592709B (en) 1999-04-29 2004-06-21 Janssen Pharmaceutica Nv Prucalopride oral solution
US6451806B2 (en) * 1999-09-29 2002-09-17 Adolor Corporation Methods and compositions involving opioids and antagonists thereof
UA73530C2 (uk) * 1999-11-10 2005-08-15 Ново Нордіск А/С Сполука з властивостями вивільнювати гормон росту
US6469030B2 (en) * 1999-11-29 2002-10-22 Adolor Corporation Methods for the treatment and prevention of ileus
WO2001056592A1 (en) * 2000-02-01 2001-08-09 Novo Nordisk A/S Use of compounds for the regulation of food intake
ES2333097T3 (es) * 2000-05-31 2010-02-17 Raqualia Pharma Inc Uso de secretagogos de la hormona de crecimiento para estimular la motilidad gastrointestinal.
IL143942A0 (en) 2000-06-29 2002-04-21 Pfizer Prod Inc Use of growth hormone secretagogues for treatment of physical performance decline
US7491695B2 (en) * 2003-06-18 2009-02-17 Tranzyme Pharma Inc. Methods of using macrocyclic modulators of the ghrelin receptor
US20050277677A1 (en) * 2004-06-10 2005-12-15 Heiman Mark L Method for treating emesis with ghrelin agonists
DK1789067T3 (da) * 2004-08-12 2012-08-27 Helsinn Healthcare Sa Anvendelse af væksthormonsekretionsfremkaldere til stimulering af mave-tarm-systemets motilitet

Also Published As

Publication number Publication date
EP1789067A4 (en) 2010-09-01
US20120077745A1 (en) 2012-03-29
SI1789067T1 (sl) 2012-09-28
WO2006020930A3 (en) 2006-11-23
KR20070064593A (ko) 2007-06-21
MX2007001477A (es) 2007-10-10
CA2576238A1 (en) 2006-02-23
PL1789067T3 (pl) 2012-10-31
DK1789067T3 (da) 2012-08-27
CY1113067T1 (el) 2016-04-13
EP1789067B8 (en) 2012-08-15
US20100087381A1 (en) 2010-04-08
IL181249A (en) 2012-02-29
US20070191283A1 (en) 2007-08-16
WO2006020930A2 (en) 2006-02-23
EP1789067B1 (en) 2012-05-23
CN101076349B (zh) 2012-08-22
EP1789067A2 (en) 2007-05-30
CA2576238C (en) 2013-11-12
KR20130048793A (ko) 2013-05-10
KR101380200B1 (ko) 2014-04-01
ES2388501T3 (es) 2012-10-16
AU2005272598B2 (en) 2011-11-17
JP2008509930A (ja) 2008-04-03
CN101076349A (zh) 2007-11-21
US8039457B2 (en) 2011-10-18
IL181249A0 (en) 2007-07-04
AU2005272598A1 (en) 2006-02-23
PT1789067E (pt) 2012-08-06

Similar Documents

Publication Publication Date Title
HK1105279A1 (en) Use of growth hormone secretagogues for stimulating the motility of the gastrointestinal system
EP1919492A4 (en) SECRETAGOGUES OF GROWTH HORMONE
EP1791590A4 (en) THERMAL SEPARATION SYSTEM FOR IMPLANTABLE DEVICES
EP1709900A4 (en) ENDOSCOPE TREATMENT SYSTEM
EP1682216A4 (en) GASTROINTESTINAL STIMULATION DEVICE
EP1799208A4 (en) AROMATIC HETEROCYCLIC COMPOUNDS AS SECRETAGOGUES OF GROWTH HORMONE
EP1793892A4 (en) Responsible stomach stimulator
AP2006003751A0 (en) Gastric retention system
GB0417078D0 (en) Flexible implant
EP1761180A4 (en) VERTEBRAL FASTENING SYSTEM
EP1706049A4 (en) FRACTURE FASTENING SYSTEM
EP1827490A4 (en) IMPLANTABLE DEVICE
EP1781311A4 (en) WACHSTUMSHORMONSEKRETAGOGE
IL201096A0 (en) Methods of treating or preventing emesis using growth hormone secretagogues
EP1937262A4 (en) COMPOSITION AND METHODS FOR STIMULATING GASTROINTESTINAL MOTILITY
IL182408A0 (en) Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds
IL156816A0 (en) Stimulation arena
EP1736093A4 (en) ENDOSCOPIC TREATMENT SYSTEM
GB0517329D0 (en) Stimulation of neurogenesis
ZA200704926B (en) Modified human growth hormone
IL162154A0 (en) Prostagandin composition for the treatment of erectile dysfunction
GB0412133D0 (en) Implantable apparatus
EP2234630A4 (en) METHOD OF STIMULATING THE MOTILITY OF THE GASTROINTESTINAL SYSTEM USING IPAMORELIN
GB2419998B (en) Remote game-play system
GB0403467D0 (en) Body warming apparatus